Orano Med is at the forefront of research in nuclear medicine and is developing new therapies against cancer. Based on its unique expertise in the production of lead-212 (Pb-212) and radiolabeling technologies, Orano Med is developing innovative radioligand therapies which consist of selectively destroying cancer cells while limiting the impact on surrounding healthy cells.
With a solid portfolio of molecules in development capable of targeting various forms of cancer, and a reliable supply chain for Pb-212, Orano Med aims to become a leader in targeted alpha therapies, in particular for patients with currently unmet medical needs.
The Executive Director, Clinical Development will be responsible for providing clinical and scientific input into the development strategy for the clinical portfolio. In addition, the Dir., Clinical Development will provide medical oversight for ongoing clinical trials, including study document development (protocols, IBs etc.), overseeing outsourced medical monitoring, participating in internal clinical data reviews and assessments for safety reports.
Job Duties:
1. Develop and support implementation of the clinical development strategy for the entire portfolio. In conjunction with program management, author clinical development plans.
2. Support interactions with health authorities by providing clinical and scientific expertise and input into drafting of various submissions (INDs, annual reports, NDAs, inquiry responses etc). Attend meetings with health authorities as needed.
3. Provide medical oversight of ongoing clinical trials:
a. Review, analyze and interpret safety information for clinical trials and provide recommendations based on emerging safety data where appropriate.
b. Compile, analyze and present safety data analysis at (internal and/or external) safety review committee meetings.
c. Maintain oversight of outsourced medical monitoring activities for quality and study plan and SOP compliance.
d. Serve as medical resource for internal and external study teams to address medical / protocol related questions.
e. Regularly attend study team meetings.
f. Work with clinical team to ensure data collected are of high quality, including contributing to development of CRFs, edit checks and data review plans and regularly performs medical data review (including coding reviews).
4. May complete medical review including causality assessments for individual case safety reports and other safety/medical related regulatory documents.
5. Lead development of scientific publications, clinical trial design and protocols, investigator brochures and other study and/or asset level documents.
Represent the company at scientific meetings, conferences and interactions with Key Opinion Leaders, Investigators, health authorities.
6. Represent the company at scientific meetings, conferences and interactions with Key Opinion Leaders, Investigators, health authorities.
All candidates must meet the following minimum requirements in order to be considered for this opportunity.
1. In-depth knowledge and prior experience in designing and implementing clinical development plans for pharmaceutical/biotechnology products. Prior experience with radioligand therapy development considered a plus.
2. Strong understanding of regulatory requirements for clinical development and ability to navigate interactions with health authorities.
3. Working knowledge of biostatistics and GCP / regulatory requirements and medical monitoring / medical data review practices.
4. Excellent verbal and written communication skills, including the ability to articulate complex scientific concepts to both technical and non-technical stakeholders. Fluency in written and spoken English
5. Licensed MD required.